How is the Palvella Therapeutics Inc. today?

The Palvella Therapeutics Inc. today is trading in the down by -2.62% at 24.13.

How has Palvella Therapeutics Inc. performed historically?

The Palvella Therapeutics Inc. is currently trading down -2.62% on an intraday basis in the past week the index rose 1.73%. The index has been up 24.57% in the past quarter and rose 77.43% in the past year. You can view this in the overview section.

What is Palvella Therapeutics Inc. Annual Net Profit?

Palvella Therapeutics Inc. Annual Net Profit fell 193.27% in the last year to $17.43 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Palvella Therapeutics Inc. Stock Price?

Palvella Therapeutics Inc. Stock Price rose 77.43% and outperformed its sector by 21.96% in the past year.

What is Palvella Therapeutics Inc. Quarterly Net profit?

Palvella Therapeutics Inc. Quarterly Net profit fell 222.75% YoY to $8.18 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Palvella Therapeutics Inc. Mutual Fund Holding?

Palvella Therapeutics Inc. Mutual Fund Holding increased by 3.06% in the last quarter to 3.36.

What is Palvella Therapeutics Inc. Interest Coverage Ratio?

Palvella Therapeutics Inc. Interest Coverage Ratio is -3.04, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Palvella Therapeutics Inc. Institutional Holding?

Palvella Therapeutics Inc. Institutional Holding increased by 6% in the last quarter to 36.6.

Palvella Therapeutics Inc. XNAS: PVLA

Palvella Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Name: Palvella Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Palvella Therapeutics Inc.
Rating: 0.96158325
Author: Trendlyne DVM scores

about

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapa...

24.13 -0.65 (-2.62%)

116.03% Gain from 52W Low

83,965 XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Palvella Therapeutics Inc. is on 10 Jun 2025 for the purpose of Palvella Therapeutics Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

4.3 / 100

Technically Bearish

34.1 / 100

No estimates available

Palvella Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Palvella Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapa...

116.03% Gain from 52W Low

SWOT Analysis

Palvella Therapeutics Inc. Live Price Chart

Palvella Therapeutics Inc. FAQ

How is Palvella Therapeutics Inc. today?

Palvella Therapeutics Inc. today is trading in the red, and is down by -2.62% at 24.13.

How has Palvella Therapeutics Inc. performed historically?

Palvella Therapeutics Inc. is currently trading down -2.62% on an intraday basis. In the past week the stock rose 1.73%. stock has been up 24.57% in the past quarter and rose 77.43% in the past year. You can view this in the overview section.